News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,076 Results
Type
Article (1599)
Company Profile (21)
Press Release (63456)
Section
Business (29714)
Career Advice (42)
Deals (4411)
Drug Delivery (4)
Drug Development (6811)
Employer Resources (8)
FDA (1113)
Job Trends (1655)
News (40047)
Policy (2018)
Tag
Academia (135)
Accelerated approval (4)
Adcomms (1)
Allergies (21)
Alliances (2157)
ALS (12)
Alzheimer's disease (175)
Antibody-drug conjugate (ADC) (36)
Approvals (1211)
Artificial intelligence (22)
Autoimmune disease (11)
Automation (5)
Bankruptcy (12)
Best Places to Work (1573)
Biosimilars (8)
Biotechnology (8)
Bladder cancer (36)
Brain cancer (3)
Breast cancer (147)
Cancer (685)
Cardiovascular disease (39)
Career advice (44)
Career pathing (2)
CAR-T (20)
CDC (1)
Cell therapy (49)
Cervical cancer (6)
Clinical research (6609)
Collaboration (63)
Compensation (88)
Complete response letters (1)
COVID-19 (151)
CRISPR (5)
C-suite (23)
Cystic fibrosis (13)
Data (970)
Depression (13)
Diabetes (25)
Diagnostics (708)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (11)
Drug pricing (8)
Duchenne muscular dystrophy (14)
Earnings (28345)
Editorial (2)
Employer branding (2)
Employer resources (8)
Events (7103)
Executive appointments (24)
FDA (1612)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (4)
Funding (66)
Gene editing (7)
Generative AI (1)
Gene therapy (33)
GLP-1 (73)
Government (242)
Grass and pollen (2)
Guidances (247)
Healthcare (1990)
HIV (6)
IgA nephropathy (17)
Immunology and inflammation (24)
Immuno-oncology (5)
Indications (10)
Infectious disease (174)
Inflammatory bowel disease (18)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (9)
Interviews (3)
IPO (3431)
Job creations (179)
Job search strategy (37)
JPM (2)
Kidney cancer (2)
Labor market (10)
Layoffs (33)
Leadership (1)
Legal (352)
Liver cancer (4)
Lung cancer (98)
Lymphoma (97)
Management (3)
Manufacturing (30)
MASH (23)
Medical device (1520)
Medtech (1526)
Mergers & acquisitions (1066)
Metabolic disorders (87)
Multiple sclerosis (25)
NASH (3)
Neurodegenerative disease (16)
Neuropsychiatric disorders (6)
Neuroscience (282)
NextGen: Class of 2026 (454)
Non-profit (220)
Now hiring (2)
Obesity (37)
Opinion (5)
Ovarian cancer (19)
Pain (13)
Pancreatic cancer (17)
Parkinson's disease (22)
Patents (25)
Patient recruitment (34)
Peanut (7)
People (1733)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (1539)
Phase 2 (2704)
Phase 3 (2808)
Pipeline (1450)
Policy (5)
Postmarket research (276)
Preclinical (501)
Press Release (1)
Prostate cancer (29)
Radiopharmaceuticals (28)
Rare diseases (74)
Real estate (249)
Recruiting (4)
Regulatory (1773)
Reports (15)
Research institute (164)
Resumes & cover letters (3)
Rett syndrome (3)
RSV (11)
Schizophrenia (16)
Series A (9)
Series B (11)
Service/supplier (1)
Sickle cell disease (7)
Special edition (4)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (132)
Stomach cancer (1)
Supply chain (7)
Tariffs (5)
Vaccines (48)
Venture capital (4)
Weight loss (18)
Women's health (8)
Date
Today (5)
Last 7 days (73)
Last 30 days (261)
Last 365 days (4155)
2026 (357)
2025 (4393)
2024 (4799)
2023 (5244)
2022 (6017)
2021 (6399)
2020 (5199)
2019 (4230)
2018 (3435)
2017 (2899)
2016 (2044)
2015 (3203)
2014 (2188)
2013 (1382)
2012 (1580)
2011 (1709)
2010 (1584)
Location
Africa (36)
Alabama (5)
Alaska (1)
Arizona (15)
Arkansas (1)
Asia (3281)
Australia (596)
California (1446)
Canada (521)
China (90)
Colorado (72)
Connecticut (50)
Delaware (84)
Europe (8966)
Florida (179)
Georgia (74)
Idaho (2)
Illinois (121)
India (4)
Indiana (95)
Iowa (2)
Japan (60)
Kansas (8)
Kentucky (9)
Louisiana (8)
Maine (14)
Maryland (195)
Massachusetts (1032)
Michigan (49)
Minnesota (86)
Missouri (19)
Montana (3)
Nevada (9)
New Hampshire (11)
New Jersey (514)
New York (402)
North Carolina (191)
North Dakota (1)
Northern California (772)
Ohio (24)
Oregon (1)
Pennsylvania (373)
Puerto Rico (1)
Rhode Island (2)
South America (75)
South Carolina (2)
Southern California (570)
Tennessee (12)
Texas (164)
United States (5428)
Utah (43)
Virginia (46)
Washington D.C. (17)
Washington State (170)
Wisconsin (9)
65,076 Results for "63".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Prostate Cancer Foundation Invests $6.3 Million in Next Generation of Prostate Cancer Researchers
February 17, 2026
·
2 min read
Press Releases
STERIS Announces Dividend of $0.63 per share - January 28, 2026
January 29, 2026
·
4 min read
Press Releases
STERIS Announces Dividend of $0.63 per share
October 30, 2025
·
4 min read
Press Releases
Antiemetics Drugs Market Size Worth USD 30.63 Billion by 2034
November 12, 2025
·
1 min read
Press Releases
Regenity Biosciences Marks 63rd FDA 510(k) Clearance with Expansion of Neurosurgical Portfolio
November 26, 2025
·
2 min read
Press Releases
arcoris bio raises CHF 6.3 million seed round to advance next-generation biomarker technology for digital pathology
November 6, 2025
·
2 min read
Press Releases
IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology
September 25, 2025
·
3 min read
Press Releases
Telix Reports $204M Revenue, Up 63% YOY
July 22, 2025
·
14 min read
Press Releases
AusperBio Raises $63 Million in Series B2 Financing to Accelerate Functional Cure Therapies for Chronic Hepatitis B
September 22, 2025
·
3 min read
Press Releases
MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension
September 23, 2025
·
10 min read
1 of 6,508
Next
